scholarly article | Q13442814 |
P356 | DOI | 10.1158/1078-0432.CCR-08-1158 |
P698 | PubMed publication ID | 19228740 |
P2093 | author name string | Jun Li | |
Ling Zhang | |||
Wen Li | |||
Mu-Sheng Zeng | |||
Mengfeng Li | |||
Li-Bing Song | |||
Chun-Ping Yu | |||
Gui-Xiang Weng | |||
Yi-xin Zeng | |||
Jin-tang Xia | |||
Qing-li Kong | |||
Li-juan Hu | |||
Hai-qing Zheng | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
P304 | page(s) | 1393-1399 | |
P577 | publication date | 2009-02-01 | |
P1433 | published in | Clinical Cancer Research | Q332253 |
P1476 | title | Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients | |
P478 | volume | 15 |
Q50074651 | A selective sphingosine-1-phosphate receptor 1 agonist SEW-2871 aggravates gastric cancer by recruiting myeloid-derived suppressor cells |
Q36251372 | A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression |
Q52663621 | ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer. |
Q39109984 | AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells. |
Q35568516 | Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer. |
Q54646109 | Antiangiogenic agents and targets: A perspective |
Q37190258 | Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells. |
Q34365926 | Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics |
Q43753628 | Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study |
Q43490599 | Clinical significance of annexin II expression in human non-small cell lung cancer |
Q91693306 | Colon Cancer and Perturbations of the Sphingolipid Metabolism |
Q38619642 | DNA damage response and sphingolipid signaling in liver diseases |
Q35754223 | Defining a role for sphingosine kinase 1 in p53-dependent tumors. |
Q30426812 | Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells |
Q37364111 | Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling. |
Q36827749 | Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance. |
Q47588678 | Etoposide Upregulates Survival Favoring Sphingosine-1-Phosphate in Etoposide-Resistant Retinoblastoma Cells |
Q91854913 | Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy |
Q26863646 | Evolving concepts in cancer therapy through targeting sphingolipid metabolism |
Q27009557 | Export of sphingosine-1-phosphate and cancer progression |
Q53309734 | Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea. |
Q33275396 | High expression of SPHK1 in sacral chordoma and association with patients' poor prognosis |
Q35583857 | High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma. |
Q40964594 | High levels of sphingolipids in human breast cancer. |
Q36414244 | Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma. |
Q53256892 | Immunohistochemical Detection of Sphingosine-1-Phosphate and Sphingosine Kinase-1 in Human Tissue Samples and Cell Lines. |
Q38394714 | Increased SPHK1 expression is associated with poor prognosis in bladder cancer |
Q51051446 | Increased expression of FOXQ1 is a prognostic marker for patients with gastric cancer. |
Q44697049 | Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition. |
Q34373466 | Interdiction of sphingolipid metabolism to improve standard cancer therapies |
Q37100281 | Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods |
Q38316610 | Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach |
Q34540244 | Loss of sphingosine kinase-1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin-induced DNA damage |
Q34165938 | Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription. |
Q37154242 | Mechanisms linking obesity and cancer |
Q38969211 | Metabolic Regulation of Apoptosis in Cancer. |
Q37045562 | MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1. |
Q92591768 | MicroRNA-9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA2 |
Q36621591 | Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2 |
Q35955451 | Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer |
Q36234717 | Oncogenic K-Ras regulates bioactive sphingolipids in a sphingosine kinase 1-dependent manner |
Q38092176 | Oncogenic properties of sphingosine kinases in haematological malignancies. |
Q34048461 | Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma |
Q33693882 | Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy |
Q40978323 | Overexpression of sphingosine kinase 1 is predictive of poor prognosis in human breast cancer |
Q43268349 | PDE5 Overexpression in Well-Differentiated Thyroid Carcinomas Is Associated with Lymph Node Metastasis. |
Q91272135 | POTEE drives colorectal cancer development via regulating SPHK1/p65 signaling |
Q90371583 | PRDM3 attenuates pancreatitis and pancreatic tumorigenesis by regulating inflammatory response |
Q88961948 | Preclinical study of the antitumor effect of sphingosine-1-phosphate receptor 1 antibody (S1PR1-antibody) against human breast cancer cells |
Q47193833 | Predictive and prognostic value of sphingosine kinase 1 expression in patients with invasive ductal carcinoma of the breast |
Q37514093 | Rab14 Suppression Mediated by MiR-320a Inhibits Cell Proliferation, Migration and Invasion in Breast Cancer. |
Q33649823 | Re-configuration of sphingolipid metabolism by oncogenic transformation |
Q85888649 | Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma |
Q35817821 | Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer |
Q92889972 | Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1 |
Q46642305 | Role of Brf1 interaction with ERα, and significance of its overexpression, in human breast cancer |
Q34017124 | Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro. |
Q34879183 | Roles of sphingosine 1-phosphate on tumorigenesis |
Q89587308 | S1P Signaling in the Tumor Microenvironment |
Q26998940 | STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer |
Q90615572 | SWELL1 promotes cell growth and metastasis of hepatocellular carcinoma in vitro and in vivo |
Q35496844 | Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer |
Q64052458 | Significance of sphingosine kinase 1 expression in feline mammary tumors |
Q34105169 | SphK1 confers resistance to apoptosis in gastric cancer cells by downregulating Bim via stimulating Akt/FoxO3a signaling |
Q42746891 | Sphingosine 1-Phosphate Receptor 2 Regulates the Migration, Proliferation, and Differentiation of Mesenchymal Stem Cells |
Q34121255 | Sphingosine 1-phosphate and cancer |
Q35108994 | Sphingosine kinase 1 and cancer: a systematic review and meta-analysis |
Q33853998 | Sphingosine kinase 1 in cancer |
Q27853204 | Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer |
Q33636769 | Sphingosine kinase 1 is overexpressed and promotes proliferation in human thyroid cancer |
Q34428778 | Sphingosine kinase 1 is required for mesothelioma cell proliferation: role of histone acetylation |
Q36621483 | Sphingosine kinase 1 is upregulated with lysophosphatidic acid receptor 2 in human colorectal cancer. |
Q33631908 | Sphingosine kinase 1 isoform-specific interactions in breast cancer |
Q90326756 | Sphingosine kinase 1 overexpression contributes to sunitinib resistance in clear cell renal cell carcinoma |
Q37614489 | Sphingosine kinase 1 promotes malignant progression in colon cancer and independently predicts survival of patients with colon cancer by competing risk approach in South asian population |
Q33598751 | Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma |
Q50021960 | Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice |
Q28069459 | Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment |
Q36627430 | Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. |
Q38967180 | Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes pancreatic cancer growth |
Q42181059 | Sphingosine-1-phosphate transporters as targets for cancer therapy. |
Q34678040 | Sphingosine‐1‐phosphate antibodies as potential agents in the treatment of cancer and age‐related macular degeneration |
Q37905015 | Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy |
Q89284626 | Stress, inflammation, and eicosanoids: an emerging perspective |
Q35831148 | TGFβ-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis |
Q49714600 | TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition |
Q35789935 | Targeting sphingosine kinase-1 to inhibit melanoma. |
Q39379449 | Targeting sphingosine-1-phosphate signaling for cancer therapy |
Q26748927 | The emerging role of FTY720 (Fingolimod) in cancer treatment |
Q34902490 | The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells |
Q90536694 | The significance of Runx2 mediating alcohol-induced Brf1 expression and RNA Pol III gene transcription |
Q34986940 | The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension |
Q38915115 | Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism |
Q37930972 | Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer |
Q35877252 | Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma |
Q39373595 | miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1. |
Search more.